Inhibition of NF-κB activity in T and NK cells results in defective effector cell expansion and production of IFN-γ required for resistance to Toxoplasma gondii

Journal of Immunology

Volumn 170, Issue 6, 2003, Pages 3139-3146

  Tato, Cristina M ^a   Villarino, Alejandro ^a   Caamaño, Jorge H ^b   Boothby, Mark ^c   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; INFECTION RESISTANCE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SURVIVAL RATE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TOXOPLASMA GONDII; TRANSGENE; TRANSGENIC MOUSE;

EID: 0037443540     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.6.3139     Document Type: Article

References (47)

1. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
2. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394.
3. Aune, T. M., A. L. Mora, S. Kim, M. Boothby, and A. H. Lichtman. 1999. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IκBα degradation. J. Immunol. 162:5805.
4. Kalli, K., C. Huntoon, M. Bell, and D. J. McKean. 1998. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-κB. Mol. Cell. Biol. 18:3140.
5. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571.
6. Caamano, J., J. Alexander, L. Craig, R. Bravo, and C. A. Hunter. 1999. The NF-κB family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:4453.
7. Harling-McNabb, L, G. Deliyannis, D. C. Jackson, S. Gerondakis, G. Grigoriadis, and L. E. Brown. 1999. Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response. Int. Immunol. 11:1431.
8. Franzoso, G., L. Carlson, L. Poljak, E. W. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Scharton-Kersten, M. Anver, et al. 1998. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147.
9. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321.
10. Speirs, K., J. Caamano, M. H. Goldschmidt, C. A. Hunter, and P. Scott. 2002. NF-κB2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell differentiation. J. Immunol. 168:4406.
11. Weih, F., G. Warr, H. Yang, and R. Bravo. 1997. Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 158:5211.
12. Denkers, E. Y., and R. T. Gazzinelli. 1998. Regulation and function of T-cell mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:569.
13. Plevy, S. E., J. H. Gemberling, S. Hsu, A. J. Dorner, and S. T. Smale. 1997. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17:4572.
14. Ouaaz, F., J. Arron, Y. Zheng, Y. Choi, and A. A. Beg. 2002. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 16:257.
15. Sanjabi, S., A. Hoffmann, H. C. Liou, D. Baltimore, and S. T. Smale. 2000. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97:12705.
16. Sica, A., L. Dorman, V. Viggiano, M. Cippitelli, P. Ghosh, N. Rice, and H. A. Young. 1997. Interaction of NF-κB and NFAT with the interferon-γ promoter. J. Biol. Chem. 272:30412.
17. Yoshimoto, T., H. Nagase, T. Ishida, J. Inoue, and H. Nariuchi. 1997. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factorκB. Eur. J. Immunol. 27:3461.
18. Aronica, M. A., A. L. Mora, D. B. Mitchell, P. W. Finn, J. E. Johnson, J. R. Sheller, and M. R. Boothby. 1999. Preferential role for NF-κB/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J. Immunol. 163:5116.
19. Ivanov, V. N., R. K. Lee, E. R. Podack, and T. R. Malek. 1997. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-κB. Oncogene 14:2455.
20. Jeremias, I., C. Kupatt, B. Baumann, I. Herr, T. Wirth, and K. M. Debatin. 1998. Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells. Blood 91:4624.
21. Mora, A., J. Youn, A. Keegan, and M. Boothby. 2001. NF-κB/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J. Immunol. 166:2218.
22. Zong, W. X., L. C. Edelstein, C. Chen, J. Bash, and C. Gelinas. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13:382.
23. Caamano, J., C. Tato, G. Cai, E. N. Villegas, K. Speirs, L. Craig, J. Alexander, and C. A. Hunter. 2000. Identification of a role for NF-κB2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J. Immunol. 165:5720.
24. Boothby, M. R., A. L. Mora, D. C. Scherer, J. A. Brockman, and D. W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB. J. Exp. Med. 185:1897.
25. Sharma, S. D., J. Verhoef, and J. S. Remington. 1984. Enhancement of human natural killer cell activity by subcellular components of Toxoplasma gondii. Cell. Immunol. 86:317.
26. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect. Immun. 62:2818.
27. Norose, K., H. S. Mun, F. Aosai, M. Chen, H. Hata, Y. Tagawa, Y. Iwakura, and A. Yano. 2001. Organ infectivity of Toxoplasma gondii in interferon-γ knockout mice. J. Parasitol. 87:447.
28. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045.
29. Sher, A., I. P. Oswald, S. Hieny, and R. T. Gazzinelli. 1993. Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150:3982.
30. Chu, Z. L., T. A. McKinsey, L. Liu, J. J. Gentry, M. H. Malim, and D. W. Ballard. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA 94:10057.
31. Lee, S. Y., D. R. Kaufman, A. L. Mora, A. Santana, M. Boothby, and Y. Choi. 1998. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor κB pathways. J. Exp. Med. 188:1381.
32. Zamorano, J., A. L. Mora, M. Boothby, and A. D. Keegan. 2001. NF-κB activation plays an important role in the IL-4-induced protection from apoptosis. Int. Immunol. 13:1479.
33. Zong, W. X., J. Bash, and C. Gelinas. 1998. Rel blocks both anti-Fas- and TNF α-induced apoptosis and an intact Rel transactivation domain is essential for this effect. Cell Death Differ. 5:963.
34. Dudley, E., F. Hornung, L. Zheng, D. Scherer, D. Ballard, and M. Lenardo. 1999. NF-κB regulates Fas/APO-1/CD95- and TCR-mediated apoptosis of T lymphocytes. Eur. J. Immunol. 29:878.
35. 1/S phase. Biochem. Biophys. Acta 249:728.
36. Doi, T. S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB Rel-Adeficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953.
37. Ferreira, V., N. Sidenius, N. Tarantino, P. Hubert, L. Chatenoud, F. Blasi, and M. Korner. 1999. In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. J. Immunol. 162:6442.
38. Iwanaga, R., K. Ohtani, T. Hayashi, and M. Nakamura. 2001. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene 20:2055.
39. Mori, N., M. Fujii, M. Hinz, K. Nakayama, Y. Yamada, S. Ikeda, Y. Yamasaki, F. Kashanchi, Y. Tanaka, M. Tomonaga, and N. Yamamoto. 2002. Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells. Int. J. Cancer 99:378.
40. Pise-Masison, C. A., R. Mahieux, M. Radonovich, H. Jiang, J. Duvall, C. Guillerm, and J. N. Brady. 2000. Insights into the molecular mechanism of p53 inhibition by HTLV type I Tax. AIDS Res. Hum. Retroviruses 16:1669.
41. Ren, H., A. Schmalstieg, D. Yuan, and R. B. Gaynor. 2002. I-κB kinase β is critical for B cell proliferation and antibody response. J. Immunol. 168:577.
42. + T lymphocytes in early IFN-γ-dependent resistance to Toxoplasma gondii. J. Immunol. 160:2565.
43. + T cells in their dependence of NF-κB/Rel signaling. Eur. J. Immunol. 29:2968.
44. McLeod, R., P. Eisenhauer, D. Mack, C. Brown, G. Filice, and G. Spitalny. 1989. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol. 142:3247.
45. Tangye, S. G., J. H. Phillips, and L. L. Lanier. 2000. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin. Immunol. 12:149.
46. Yang, J., H. Zhu, T. L. Murphy, W. Ouyang, and K. M. Murphy. 2001. IL-18stimulated GADD45 β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2:157.
47. Sanders, B., I. Hoiden, U. Andersson, E. Moller, and J. S. Abrams. 1993. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. J. Immunol. Methods 166:201.